- Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. Kelner, M.J., McMorris, T.C., Rojas, R.J., Estes, L.A., Suthipinijtham, P. Invest. New. Drugs (2008)